等待开盘 09-20 09:30:00 美东时间
+1.330
+1.28%
Travere Therapeutics (NASDAQ:TVTX) traded higher in the premarket on Friday after the U.S. Food and Drug Administration (FDA) granted full approval for its kidney disease drug, Filspari (sparsentan). ...
09-06 18:45
Ligand Pharmaceuticals's (NYSE:LGND) short percent of float has fallen 14.7% si...
08-16 21:01
With so much focus on large-cap (SP500)and growth stocks, Roth MKM highlighted the small-cap (RTY) value pocket of the U.S. equity market and listed some “bullish” stocks in the group. Looking at the...
08-12 23:34
Ligand Pharmaceuticals (NASDAQ:LGND) announced that its President and Chief Operating Officer, Matthew Korenberg, will be departing from the company. Filing More on Ligand Pharmaceuticals Ligand Phar...
08-03 05:53
Ligand Pharma (LGND) has provided an announcement. Ligand Pharmaceuticals has a...
08-03 05:51
In the preceding three months, 6 analysts have released ratings for Ligand Phar...
07-30 20:01
Proposed merger to create a Nasdaq-listed, clinical-stage biopharmaceutical com...
07-24 18:30
BTIG screened for relative leadership during the market’s recent pullback and identified 12 stocks it expects to fare well over the coming months, including private equity firm Blackstone (NYSE:BX), b...
07-23 22:38
Johnson & Johnson (NYSE:JNJ) posted better-than-expected financials for Q2 2024 on Wednesday, thanks mainly to its pharma unit, currently known as Innovative Medicine, while its MedTech division fell ...
07-17 19:16
Ligand Pharmaceuticals (NASDAQ:LGND) said it will acquire APEIRON Biologics for $100 million in cash. Additionally, the company will pay APEIRON shareholders additional consideration based on future c...
07-08 19:17